Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Peest

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Onkologie|June 1, 1986
Current results of a multicenter trial in multiple myelomaD Peest, H J Schmoll, I Schedel, et al.
British Journal of Haematology|February 1, 1995
Low-dose recombinant interleukin-2 therapy in advanced multiple myelomaD Peest, R Leo, S Bloche, et al.
Annals of Hematology|October 1, 1993
Effect of recombinant human erythropoietin after allogenic bone marrow transplantationH Link, T Brune, G Hübner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groupsD Peest, R Coldewey, H Deicher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
Onkologie|February 1, 1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAMDex) therapy for multiple myeloma. Early results of a multicenter trial. The German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)D Peest, H Deicher, W Fett, et al.
Onkologie|December 1, 1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Interferons in the treatment of multiple myelomaD E Bergsagel, P von Wussow, R Alexanian, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Onkologie|June 1, 1986
Current results of a multicenter trial in multiple myelomaD Peest, H J Schmoll, I Schedel, et al.
British Journal of Haematology|February 1, 1995
Low-dose recombinant interleukin-2 therapy in advanced multiple myelomaD Peest, R Leo, S Bloche, et al.
Annals of Hematology|October 1, 1993
Effect of recombinant human erythropoietin after allogenic bone marrow transplantationH Link, T Brune, G Hübner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groupsD Peest, R Coldewey, H Deicher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
Onkologie|February 1, 1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAMDex) therapy for multiple myeloma. Early results of a multicenter trial. The German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)D Peest, H Deicher, W Fett, et al.
Onkologie|December 1, 1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Interferons in the treatment of multiple myelomaD E Bergsagel, P von Wussow, R Alexanian, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Pageof 5